Ftse Mib
35.355,87
0,58%
DAX
18.869,36
0,78%
S&P 500
5.300,68
1,03%
NASDAQ
16.715,35
1,24%
Bitcoin
65.083,39
5,75%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IceCure Medical Ltd (ICCM) IceCure Medical Ltd (ICCM) Notizie

IceCure Medical Ltd

ICCM
1,20
0,08 (7,14%)
Ultimo aggiornamento: 19:45:57
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/5/202414:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/5/202414:30PRNUSIndependent Study Results in Japan Demonstrate Zero (0%)..
15/4/202414:35PRNUSIceCure Medical Reports Final ICE3 Breast Cancer..
03/4/202414:30PRNUSIceCure Medical Reports Full Year 2023 Financial Results:..
03/4/202413:11IHMARKETNEWSU.S. Futures Dip in Pre-Market, May WTI and June Brent Crude..
02/4/202414:30PRNUSIceCure Submits FDA Regulatory Filing for New XSense™..
27/3/202413:30PRNUSIceCure Medical to Report 2023 Full Year Financial &..
19/3/202413:30PRNUSIceCure Medical Reports Positive Topline Results From ICE3..
12/3/202413:30PRNUSIceCure Receives Notice of Patent Allowance in Japan for a..
07/3/202414:30PRNUSIceCure Medical to Present at 34th Annual Oppenheimer..
04/3/202414:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/3/202414:30PRNUSIceCure's ProSense® a Promising Alternative Treatment for..
27/2/202414:00PRNUSFourth BRIIT Conference in India Features IceCure's..
26/2/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/2/202414:00PRNUSStudy Using IceCure's ProSense® Treatment Results in 100%..
15/2/202414:00PRNUSIceCure's ProSense® to be Featured at Two Upcoming Medical..
30/1/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202414:00PRNUSU.S. FDA Grants IceCure Medical's Appeal: Reopens De Novo..
29/1/202414:00PRNUSIceCure Medical's Breast Cryoablation Gains Prominence in..
16/1/202414:00PRNUSIceCure Medical's ProSense® Featured at Indian Society of..
12/1/202422:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/1/202422:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202422:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/1/202422:05GLOBEIceCure Medical Regains Compliance with Nasdaq Minimum..
10/1/202414:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202414:00PRNUSIceCure Medical CEO Issues Letter to Shareholders & Reports..
03/1/202414:00PRNUSNew Study Reports IceCure's ProSense® Boosts Immune Response..
13/12/202314:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202314:00PRNUSStudy Using IceCure's ProSense® Finds: "Cryoablation Allows..
29/11/202314:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202314:00PRNUSIceCure's ProSense® Deepens Regulatory Approval in India
28/11/202314:00PRNUSIceCure System Successfully Treated Kidney Cancer Tumor with..
15/11/202314:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202314:00PRNUSIceCure Medical Reports Financial Results as of and for the..
15/11/202313:30PRNUSIceCure Medical Files Appeal with U.S. FDA Requesting a..
08/11/202314:00PRNUSIceCure Medical to Report Third Quarter 2023 Financial &..
06/11/202314:00PRNUSSubstantial Evidence-Based Data Currently Being Generated by..
03/11/202321:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/11/202321:00PRNUSIceCure Medical Announces Receipt of Nasdaq Minimum Bid..
30/10/202313:00PRNUSIceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence..
25/10/202314:00PRNUSIndependent Scientific Paper by Doctors Using IceCure's..
05/10/202314:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/10/202314:00PRNUSWomen Deemed Inoperable for Breast Cancer Benefitted from..
02/10/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202314:00PRNUSIndependent Study Validates IceCure's ProSense Cryoablation..
22/9/202314:00PRNUSRenowned Spanish Radiologist Lucía Graña-López to Present..
20/9/202313:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/9/202313:00PRNUSIceCure Medical Receives FDA Response to De Novo..
08/9/202314:00PRNUSIceCure Medical to Join Hands-On Cryoablation Session with..
05/9/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 1,13 Min: 1,13 Max: 1,21
Chiusura: 1,12

La tua Cronologia

NASDAQ
ICCM
IceCure Medical
NASDAQ
CIDM
Cinedigm
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network